therapeutic vaccines Latest News

A new report by visiongain predicts that the world market for vaccines will reach $48bn in 2015. From this market, vaccine contract manufacturing will reach $0.62bn in 2015.

Immune Response BioPharma, Inc. Files for Orphan Designation of Blockbuster RA Vaccine RAVAX for expanded use into the rare disease Juvenile Rheumatoid Arthritis.

Immune Response BioPharma, Inc. Files for Orphan Designation for Blockbuster Drug NeuroVax for Multiple Sclerosis

Immune Response BioPharma, Inc. Provides Business Update Sees Blockbuster MS Drug NeuroVax the Gold Standard of Care for MS and a Partnership by the end of Q1 2013

A new report by visiongain predicts that the 2012 world market for vaccines to treat human beings will reach $33.8 billion. That revenue forecast appears in World Vaccines Market 2012-2022, published in July 2012.

Biopharma Report’s “Lung Cancer Vaccines: Pipeline, Strategies and Clinical” is now available at ReportsnReports.com.